Czop J K, Austen K F
J Immunol. 1982 Dec;129(6):2678-81.
Intact human plasma fibronectin of 44,000 m.w. and a fibronectin fragment of 180,000 m.w. promote dose-dependent adherence of gelatin-coated particles to human monocytes without phagocytosis. Both of these proteins, however, augment monocyte ingestion of gelatin-coated targets that are particulate activators of the alternative complement pathway or of nonactivators bearing IgG. Unlike intact fibronectin, the 180,000 m.w. fragment also binds directly to particulate activators that lack gelatin to augment their phagocytosis by human monocytes. Prior attachment to monocytes of gelatin-coated sheep erythrocytes bearing increasing concentrations of intact fibronectin decreases in a dose-dependent fashion the capacity of these monocytes to engage in augmented phagocytosis of particulate activators opsonized with the 180,000 m.w. fibronectin. Occupation of the monocyte fibronectin receptors with particle-bound, intact fibronectin does not decrease monocyte phagocytosis of plain particulate activators or of IgG-coated particles. Thus, the 180,000 m.w. fibronectin fragment both directly opsonizes particulate activators and interacts with monocyte fibronectin receptors to promote particle adherence, thereby enhancing phagocytosis through a concerted action with the distinct receptors for particulate activators.
分子量为44,000的完整人血浆纤连蛋白和分子量为180,000的纤连蛋白片段可促进明胶包被颗粒与人单核细胞的剂量依赖性黏附,且不发生吞噬作用。然而,这两种蛋白质都会增强单核细胞对明胶包被靶标的摄取,这些靶标是替代补体途径的颗粒激活剂或带有IgG的非激活剂。与完整的纤连蛋白不同,分子量为180,000的片段还直接结合缺乏明胶的颗粒激活剂,以增强人单核细胞对它们的吞噬作用。预先将携带浓度不断增加的完整纤连蛋白的明胶包被绵羊红细胞附着于单核细胞,会以剂量依赖性方式降低这些单核细胞对用分子量为180,000的纤连蛋白调理的颗粒激活剂进行增强吞噬作用的能力。用颗粒结合的完整纤连蛋白占据单核细胞纤连蛋白受体不会降低单核细胞对普通颗粒激活剂或IgG包被颗粒的吞噬作用。因此,分子量为180,000的纤连蛋白片段既直接调理颗粒激活剂,又与单核细胞纤连蛋白受体相互作用以促进颗粒黏附,从而通过与颗粒激活剂的不同受体协同作用来增强吞噬作用。